Exited position

Ray Dalio’s Addus Homecare Corp (ADUS) position

Reported position history, portfolio importance and verified filing changes from public SEC disclosures.

Bridgewater Associates, LPVerified through Q2 2026
Relationship snapshot

At a glance

The full verified relationship, including prior ownership episodes and exits where supported.

First reportedQ2 2021Earliest verified positive filing snapshot
Latest statusExited positionBased on the latest supported relationship state
Peak shares25.10KHighest verified quarter-end share count
Quarters reported15Verified quarters with shares above zero
What happened?

Bridgewater Associates, LP first reported Addus Homecare Corp in Q2 2021. The reported position was increased and reduced across later filings. The latest verified relationship event shows that Bridgewater Associates, LP sold the entire position in Q1 2025, and the stock is no longer reported in the latest verified portfolio.

Verified SEC history

Position over time

See the same verified relationship through reported shares, portfolio weight or reported value.

Metric

Gaps indicate periods that cannot be safely connected or where a verified corporate action changes the raw share scale. Stock price, when available, is market context and not a transaction price.

Key filing events

What changed

Latest filing plus the most meaningful reported changes. Unchanged quarters are collapsed by default.

Q1 2025
Sold the entire position−2.08K shares · No shares reported at quarter-end
Q4 2024
Sold 74.1% of the position−5.94K shares · 2.08K shares remained
Filing context

Quarter-end price $125.35 · Estimated holding basis $89.74

Q3 2024
Sold 47.2% of the position−7.17K shares · 8.02K shares remained
Filing context

Quarter-end price $133.03 · Estimated holding basis $89.74

Q2 2024
Bought 3.3% more+486 shares · 15.19K shares reported after the change
Filing context

Quarter-end price $116.11 · Estimated holding basis $89.74

Q1 2024
Sold 14.7% of the position−2.54K shares · 14.70K shares remained
Filing context

Quarter-end price $103.34 · Estimated holding basis $88.86

Q4 2023
Sold 9.5% of the position−1.81K shares · 17.24K shares remained
Filing context

Quarter-end price $92.85 · Estimated holding basis $88.86

Portfolio importance

How important was Addus Homecare Corp in Bridgewater Associates, LP’s reported portfolio?

Relative importance is measured only within the verified primary non-option reported portfolio for each quarter.

Last reported portfolio weight0.0%Q4 2024
Last reported rank#646of 691 reported positions
Peak portfolio weight0.0%Q1 2023
Best historical rank#455Q1 2023
At peak importanceQ1 2023
ADUS
0.0%
Largest holding
5.3%
Cross-investor discovery

Who else owns Addus Homecare Corp?

Also reported by 1 other tracked investor in their latest verified filings.

Explore Addus Homecare Corp across all tracked investors →
SEC evidence & methodology

SEC filing evidence

Market context and filing-derived values are kept separate from actual transaction prices, which 13F filings do not disclose.

Latest verified stock price$117.072026-09-18

Market context only; not an investor transaction price.

Latest verified investor filingQ2 2026 · filed 2026-08-14
Open SEC filing ↗

This tracker follows Bridgewater Associates, LP’s Form 13F disclosures, not Ray Dalio’s personal brokerage account. Form 13F reports quarter-end positions later and does not reveal exact trade dates or execution prices.